Ages2Come
Menu
View all results →
Categories
⚡ Breaking
DOJ charges ex-FBI Director James Comey in new case NASA’s Perseverance Offers Clues to Protect Crews From Mars Dust Watch out, YouTube; Instagram goes from short-form to 90-minute videos JetBlue posts bigger loss on fuel costs, but CEO says margins improving Best Dyson Vacuum Deals for Dyson Week 2026 Meta, SpaceX, Anthropic stoke the AI funding frenzy. What it means for our stocks Anker’s Halloween Sale Takes 20% Off Our Favorite Chargers and Power Banks Anthropic's IPO puts power in the hands of founders, giving everyday shareholders little voice Flexell Space Establishes French Subsidiary to Strengthen European Presence Apple AirTags (2nd Gen) Are on Sale for 20% Off Right Now DOJ charges ex-FBI Director James Comey in new case NASA’s Perseverance Offers Clues to Protect Crews From Mars Dust Watch out, YouTube; Instagram goes from short-form to 90-minute videos JetBlue posts bigger loss on fuel costs, but CEO says margins improving Best Dyson Vacuum Deals for Dyson Week 2026 Meta, SpaceX, Anthropic stoke the AI funding frenzy. What it means for our stocks Anker’s Halloween Sale Takes 20% Off Our Favorite Chargers and Power Banks Anthropic's IPO puts power in the hands of founders, giving everyday shareholders little voice Flexell Space Establishes French Subsidiary to Strengthen European Presence Apple AirTags (2nd Gen) Are on Sale for 20% Off Right Now
Health / General

The Trump administration's move to end subsidies for Medicare drug plans could cost consumers

Source: nprNews July 29, 2026 · 13:58
The Trump administration's move to end subsidies for Medicare drug plans could cost consumers
Photo by Joshua Santos · Pexels
From the publisher
Federal subsidies that have helped defray insurers' Medicare drug costs will disappear at the end of the year. Millions of beneficiaries could face higher premiums in 2027.
Read original article ← Back to General

The original article opens on the publisher's website.

More from General

View topic →

Related to this story

J&J's potential 'game-changer' drug — plus, what Microsoft's mass buyouts mean
Oct 26 · 11:45
Cramer: I asked some tech insiders what to buy. They surprisingly said this drug stock
Oct 26 · 10:00
U.S. measles cases more than double what they were last year as outbreak spreads
Oct 25 · 13:35
Biotech stocks are surging. How investors can play the new drug innovation boom
Oct 24 · 11:56

Explore

Health nprNews
Trending topics
#Best Dyson Vacuum Deals for Dyson … #Prediction market traders think jo… #Google Fitbit Edge: Specs, Feature… #Trump administration pushes for fo… #NASA Invites Media to Internationa… #Brazil's Lula wins presidential el…